TCMDC-135051, a Highly Selective PfCLK3 Inhibitor, Has Potential to Treat Malaria
PfCLK3 is a protein kinase essential for maintaining the asexual blood stage of both P. falciparum and P. berghei. In mammalian cells, the CLK protein kinase family and the closely related SRPK family…